» Articles » PMID: 27912930

Prognostic Significance of Venous Invasion and Maximum Standardized Uptake Value of F-FDG PET/CT in Surgically Resected T1N0 Esophageal Squamous Cell Carcinoma

Overview
Publisher Elsevier
Date 2016 Dec 4
PMID 27912930
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to analyze the risk factors of recurrence in patients with early stage esophageal squamous cell carcinoma (ESCC).

Methods: We retrospectively analyzed the medical records of 190 patients with confirmed T1N0M0 ESCC after curative esophagectomy. The following potential prognostic factors for recurrence were investigated: age, sex, pathologic T category, tumor location, differentiation grade, tumor size, venous invasion, angiolymphatic invasion, perineural invasion and the maximum standardized uptake value (SUVmax) of the primary tumor.

Results: There were 174 male and 16 female patients with a median age of 66.0 years (range, 42.0-79.0 years). The pathologic status of the surgically resected ESCCs was T1a in 93 patients (48.9%) and T1b in 97 patients (51.1%). The median number of dissected lymph nodes was 35 (range, 10 to 86), and all lymph nodes were negative for tumors. The multivariate analysis showed presence of venous invasion [HR (hazard ratio), 11.433; P < 0.001) and SUVmax ≥ 3.2 (HR, 2.830; P = 0.011) as independent risk factors for recurrence. The 5-year recurrence-free survival (RFS) was 25.0% for patients with venous invasion and 78.9% for those without (P < 0.001). The 5-year RFS was 67.1% for patients with an SUVmax ≥3.2 and 81.5% for those with an SUVmax <3.2 (P = 0.003).

Conclusions: Venous invasion and high SUVmax could be important prognostic factors coupled with the TNM staging system, in patients with early stage ESCC.

Citing Articles

F-fluorodeoxyglucose positron emission tomography/computed tomography parameters are associated with histological outcomes in superficial esophageal squamous cell carcinoma.

Tanaka H, Hashiguchi K, Tabuchi M, Nessipkhan A, Akashi T, Shiota J Sci Rep. 2024; 14(1):17493.

PMID: 39080310 PMC: 11289315. DOI: 10.1038/s41598-024-65066-5.


Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer.

Matsui K, Kawakubo H, Matsuda S, Hirata Y, Irino T, Fukuda K Esophagus. 2023; 20(4):679-690.

PMID: 37222963 DOI: 10.1007/s10388-023-01014-y.


Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.

Liu L, Lin H, Shen G, Liu Y, Qin X, Yuan Y BMC Cancer. 2023; 23(1):370.

PMID: 37087442 PMC: 10122816. DOI: 10.1186/s12885-023-10858-7.


Microscopic venous invasion is a predictor of prognosis in patients with esophageal squamous cell carcinoma undergoing ineffective neoadjuvant chemotherapy and surgery.

Tanishima Y, Takahashi K, Nishikawa K, Ishikawa Y, Yuda M, Tanaka Y Esophagus. 2023; 20(4):651-659.

PMID: 37081314 DOI: 10.1007/s10388-023-01005-z.


Grading criteria for venous invasion in thoracic esophageal squamous cell carcinoma.

Wang A, Liu X, Lu L, Wang S, Chen X J Cardiothorac Surg. 2023; 18(1):111.

PMID: 37029384 PMC: 10082538. DOI: 10.1186/s13019-023-02272-8.